LACEY HALL: Open Payments
NPI 1316555006 · NIXA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 65 payments from 18 companies in 2025. Trend: 2023 $266 · 2024 $3,071 · 2025 $1,299
Food & beverage: $1,278Education: $20
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $226 |
| Novartis Pharmaceuticals Corporation | 16 | $151 |
| Novo Nordisk Inc | 10 | $141 |
| Boston Scientific Corporation | 2 | $132 |
| CVRx, Inc. | 1 | $127 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $97 |
| HEARTFLOW, INC. | 4 | $78 |
| Amgen Inc. | 2 | $50 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
Products named: FARXIGA, WATCHMAN FLX, Barostim Neo System, LEQVIO, LifeVest, Wegovy, FFRct, REPATHA.
Industry payments across MO — which companies pay providers there.
